A True Contrarian Play on an AI ‘Casualty’
Wall Street has turned negative on this software giant. Here’s why I’m willing to step in.
Bearish Bets: Pressure Mounts on These 3 Names
Three stocks that have changed direction and now see lower prices ahead.
These Two Biotechs Offer Stability in a Crazy Market
A slow and steady approach with these stable biopharma stocks offers refuge from a market that feels ready to pop.
New Delta Trade Idea After Unexpected Guidance
The airline turned some heads on Wall Street while “executing from a position of strength.”
Who the Heck Is Inseego? We’re Buying the Small-Cap 5G Firm
We’re taking a closer look at the defense contractor following a recent peak.
Strong Grades for 3 Bank Stocks With Earnings on Deck
Momentum in the banking sector is building just as the biggest names in the industry are preparing to report earnings.
Here’s What Should Terrify Any Long-Term PepsiCo Investor
Pepsi lost its fizz years ago — and this quarter didn’t change that.
Selling Rackspace After Guidance Cut Drives a Change of Strategy
The firm cut guidance and then announced a pivot, so we’re going to trim the position before entering the red.
Where to Short Crude Oil? Part 2 of Our Game Plan
After sharing a long trade idea for crude, here’s a short one to capitalize on the volatility.
I Don’t Know About You, But I’m Feeling These 22 Biotech Stocks
The market is in a transitional phase as we await earnings.